tradingkey.logo
搜索

USANA Health Sciences Inc

USNA
添加自选
14.490USD
+0.350+2.48%
收盘 09-21 16:00美东
267.53M总市值
29.25市盈率 TTM
盘后交易 18:30 (美东)14.490USD+0.010+0.07%

关于 {index_name} USANA Health Sciences Inc 公司

USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.

USANA Health Sciences Inc 简介

公司代码USNA
公司名称USANA Health Sciences Inc
上市日期Oct 28, 1993
CEOBrown (Jim H)
员工数量1700
证券类型Ordinary Share
年结日Oct 28
公司地址3838 West Parkway Blvd.
城市SALT LAKE CITY
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编84120-6336
电话18019547100
网址https://www.usana.com/
公司代码USNA
上市日期Oct 28, 1993
CEOBrown (Jim H)

USANA Health Sciences Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Kevin G. Guest
Mr. Kevin G. Guest
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
47.07K
-0.00%
Mr. Kevin G. Guest
Mr. Kevin G. Guest
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
47.07K
-0.00%
Mr. Kevin G. Guest
Mr. Kevin G. Guest
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
47.07K
-0.00%
Mr. Jim H. Brown
Mr. Jim H. Brown
President, Chief Executive Officer
President, Chief Executive Officer
17.45K
-38.10%
Dr. Timothy E. Wood, Ph.D.
Dr. Timothy E. Wood, Ph.D.
Independent Director
Independent Director
11.84K
+10.34%
Dr. Timothy E. Wood, Ph.D.
Dr. Timothy E. Wood, Ph.D.
Independent Director
Independent Director
11.84K
+10.34%
Dr. Timothy E. Wood, Ph.D.
Dr. Timothy E. Wood, Ph.D.
Independent Director
Independent Director
11.84K
+10.34%
Mr. Walter Noot
Mr. Walter Noot
Chief Operating Officer
Chief Operating Officer
9.26K
--
Mr. Walter Noot
Mr. Walter Noot
Chief Operating Officer
Chief Operating Officer
9.26K
--
Mr. Walter Noot
Mr. Walter Noot
Chief Operating Officer
Chief Operating Officer
9.26K
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Kevin G. Guest
Mr. Kevin G. Guest
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
47.07K
-0.00%
Mr. Kevin G. Guest
Mr. Kevin G. Guest
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
47.07K
-0.00%
Mr. Kevin G. Guest
Mr. Kevin G. Guest
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
47.07K
-0.00%
Mr. Jim H. Brown
Mr. Jim H. Brown
President, Chief Executive Officer
President, Chief Executive Officer
17.45K
-38.10%
Dr. Timothy E. Wood, Ph.D.
Dr. Timothy E. Wood, Ph.D.
Independent Director
Independent Director
11.84K
+10.34%
Dr. Timothy E. Wood, Ph.D.
Dr. Timothy E. Wood, Ph.D.
Independent Director
Independent Director
11.84K
+10.34%

常见问题

USANA Health Sciences Inc的前五大股东是谁?

USANA Health Sciences Inc 的前五大股东如下:Mr. Kevin G. Guest

有多少机构持有USANA Health Sciences Inc(USNA)的股份?

截至2026Q1,共有371家机构持有USANA Health Sciences Inc的股份,合计持有的股份价值约为11.35M,占公司总股份的61.48%。与2025Q4相比,机构持股有所增加,增幅为-673041.00。

哪个业务部门对USANA Health Sciences Inc的收入贡献最大?

在2026Q1,USANA® Nutritionals业务部门对USANA Health Sciences Inc的收入贡献最大,创收162.99M,占总收入的73.00%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有